MBrace Therapeutics

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors	cancer, neoplasm	Recruiting	Phase 1 / Phase 2	2026-03-02		NCT06014658
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors	Digestive System Diseases, Digestive System Neoplasms, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, breast cancer, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, intestinal disorder, lung disorder, lung neoplasm, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, pancreas disorder, pancreatic neoplasm, prostate cancer, prostate disorder, rectal disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder	Recruiting	Phase 1 / Phase 2	2026-02-17		NCT07145255

Clinical trials